Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Diffuse large B-cell lymphoma can be classified by gene expression profiling into germinal center and activated B-cell subtypes with different prognoses after rituximab-CHOP. The importance of previously recognized prognostic markers, such as Bcl-2 protein expression and BCL2 gene abnormalities, has...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Visco, Carlo, Tzankov, Alexander, Xu-Monette, Zijun Y., Miranda, Roberto N., Tai, Yu Chuan, Li, Yan, Liu, Wei-min, d'Amore, Emanuele S. G., Li, Yong, Montes-Moreno, Santiago, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Wang, Huan-You, Dunphy, Cherie H., His, Eric D., Zhao, X. Frank, Choi, William WL., Zhao, Xiaoying, van Krieken, J. Han, Huang, Qin, Ai, Weiyun, O'Neill, Stacey, Ponzoni, Maurilio, Ferreri, Andres JM., Kahl, Brad S., Winter, Jane N., Go, Ronald S., Dirnhofer, Stephan, Piris, Miguel A., Møller, Michael B., Wu, Lin, Medeiros, L. Jeffrey, Young, Ken H.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2013
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3561433/
https://ncbi.nlm.nih.gov/pubmed/22929980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.066209
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados